Chronic pain and PTSD are associated, with the pain varying as a function of the course of PTSD, suggesting a potential path for treatment planning.

The prevalence of frailty was 33% among a US-wide cohort of patients with RMDs, with the highest rates found among those with fibromyalgia or CTDs.

The Prognostic Nutritional Index and systemic oxidative stress score are independently associated with poorer prognosis of low-risk MDS.

Alopecia areata has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity.

For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.

From 2010 to 2023, physician exit rates from traditional Medicare increased, according to study findings published in JAMA Health Forum.

Patients with chronic low back pain may exhibit worsened cognitive function compared with pain-free individuals.

Bedtime TNX-102 SL was safe and effective for the treatment of fibromyalgia by improving symptoms of pain, disrupted sleep, and fatigue.

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

For adults with NLUTD or IC/BPS, robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty is feasible.

Cannabis use disorder is associated with increased risk of benign salivary gland tumors, according to study findings.

From 2008 to 2023, there was an increase in the prevalence of extremely severe obesity in children, especially among older adolescents and non-Hispanic Black children.